| Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label … TSK Mok, YL Wu, I Kudaba, DM Kowalski, BC Cho, HZ Turna, G Castro, ... The Lancet 393 (10183), 1819-1830, 2019 | 2871 | 2019 |
| First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open … L Paz-Ares, TE Ciuleanu, M Cobo, M Schenker, B Zurawski, J Menezes, ... The Lancet Oncology 22 (2), 198-211, 2021 | 975 | 2021 |
| Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN … JW Goldman, M Dvorkin, Y Chen, N Reinmuth, K Hotta, D Trukhin, ... The Lancet Oncology 22 (1), 51-65, 2021 | 436 | 2021 |
| First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in advanced non-small-cell lung cancer: CheckMate 9LA 2-year update M Reck, TE Ciuleanu, M Cobo, M Schenker, B Zurawski, J Menezes, ... ESMO open 6 (5), 100273, 2021 | 150 | 2021 |
| Lung cancer in Brazil LH Araujo, C Baldotto, G Castro Jr, A Katz, CG Ferreira, C Mathias, ... Jornal Brasileiro de Pneumologia 44, 55-64, 2018 | 133 | 2018 |
| PD-L1 expression by Tumor Proportion Score (TPS) and Combined Positive Score (CPS) are similar in non-small cell lung cancer (NSCLC) P De Marchi, LF Leal, VD da Silva, ECA da Silva, VCC de Lima, RM Reis Journal of Clinical Pathology 74 (11), 735-740, 2021 | 67 | 2021 |
| Câncer de pulmão no Brasil LH Araujo, C Baldotto, G Castro Jr, A Katz, CG Ferreira, C Mathias, ... Jornal Brasileiro de Pneumologia 44, 55-64, 2018 | 67 | 2018 |
| MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol LMRB Arantes, AC Laus, ME Melendez, AC de Carvalho, BP Sorroche, ... Oncotarget 8 (6), 9911, 2017 | 67 | 2017 |
| Determinants of COVID-19 mortality in patients with cancer from a community oncology practice in Brazil BL Ferrari, CG Ferreira, M Menezes, P De Marchi, J Canedo, AC Melo, ... JCO global oncology 7, 46-55, 2021 | 49 | 2021 |
| Mutational profile of Brazilian lung adenocarcinoma unveils association of EGFR mutations with high Asian ancestry and independent prognostic role of KRAS mutations LF Leal, FE De Paula, P De Marchi, L de Souza Viana, GDJ Pinto, ... Scientific reports 9 (1), 3209, 2019 | 44 | 2019 |
| Detection of ALK fusion transcripts in FFPE lung cancer samples by NanoString technology AF Evangelista, MF Zanon, AC Carloni, FE de Paula, MA Morini, ... BMC Pulmonary Medicine 17, 1-8, 2017 | 38 | 2017 |
| Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma AA Jacinto, ES Batalha Filho, LS Viana, P De Marchi, RC Capuzzo, ... BMC cancer 18, 1-9, 2018 | 31 | 2018 |
| DNA methylation markers from negative surgical margins can predict recurrence of oral squamous cell carcinoma BP Sorroche, FR Talukdar, SCS Lima, ME Melendez, AC de Carvalho, ... Cancers 13 (12), 2915, 2021 | 15 | 2021 |
| The CANOPY program: Canakinumab in patients (pts) with non-small cell lung cancer (NSCLC). LG Paz-Ares, EB Garon, A Ardizzoni, F Barlesi, BC Cho, G Castro, ... Journal of Clinical Oncology 37 (15_suppl), TPS9124-TPS9124, 2019 | 15 | 2019 |
| Criteria for eligibility to cisplatin in the curative treatment of head and neck cancer: consensus opinion from a panel of experts G de Castro Jr, GV Alves, AF Castro, ALF Chaves, P De Marchi, ... Critical Reviews in Oncology/Hematology 131, 30-34, 2018 | 15 | 2018 |
| Exergame training-induced neuroplasticity and cognitive improvement in institutionalized older adults: A preliminary investigation MM Cavalcante, I Fraga, B Dalbosco, P De Marchi, L Iraci, MEB da Silva, ... Physiology & Behavior 241, 113589, 2021 | 14 | 2021 |
| Real-World Prevalence of PD-L1 Expression Among Tumor Samples From Patients With Non–Small-Cell Lung Cancer ACZ Gelatti, VCC de Lima, H Freitas, G Werutsky, AM Gaiger, C Klock, ... Clinical Lung Cancer 21 (6), e511-e515, 2020 | 11 | 2020 |
| The role of single-nucleotide polymorphism (SNPs) in toxicity of induction chemotherapy based on cisplatin and paclitaxel in patients with advanced head and neck cancer P De Marchi, ME Melendez, AC Laus, PA Kuhlmann, AC de Carvalho, ... Oral oncology 98, 48-52, 2019 | 11 | 2019 |
| Frequency of KRAS p.Gly12Cys Mutation in Brazilian Patients With Lung Cancer R Cavagna, F Escremim de Paula, D Sant'Anna, I Santana, VD da Silva, ... JCO Global Oncology 7, 639-645, 2021 | 10 | 2021 |
| Feasibility of methylated ctDNA detection in plasma samples of oropharyngeal squamous cell carcinoma patients LM de Jesus, MB Dos Reis, RS Carvalho, C Scapulatempo Neto, ... Head & Neck 42 (11), 3307-3315, 2020 | 10 | 2020 |
